AFM
VANI icon

Anson Funds Management’s Vivani Medical VANI Stock Holding History

Anson Funds Management’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,545
Closed -$277K – 56
2017
Q1 		$277K Buy
9,545
+8,249
+636% +$316K 0.12% 38
2016
Q4 		$61K Buy
+1,296
New +$74K 0.02% 87

Other funds holding VANI

VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CD
Carl Domino West Palm Beach, Florida $82M AUM 19.36% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Anson Funds Management's VANI Position: Q2 2017 in Review

Anson Funds Management sold out of Vivani Medical (VANI) in Q2 2017, closing a stake of 9,545 shares — an estimated $277K sold.

Anson Funds Management first reported a position in VANI in Q4 2016 and held it in 2 quarters. The position peaked at $277K in Q1 2017. 44 funds tracked by Wall St. Rank hold VANI as of Q2 2017.

  • Anson Funds Management reported no remaining Vivani Medical position as of Q2 2017 after selling out during the quarter.
  • Anson Funds Management sold 9,545 Vivani Medical shares in Q2 2017, an estimated $277K.
  • Anson Funds Management first reported a position in Vivani Medical in Q4 2016 and held it in 2 quarters.
  • Anson Funds Management's Vivani Medical position peaked at $277K in Q1 2017.
  • 44 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2017.

Based on Anson Funds Management's 13F filing for Q2 2017, filed 14 Aug 2017.